Mending a Broken Heart: Treatment of Stress-Induced Heart Failure after Solid Organ Transplantation
نویسندگان
چکیده
منابع مشابه
Mending a broken heart: the role of mitophagy in cardioprotection.
The heart is highly energy dependent with most of its energy provided by mitochondrial oxidative phosphorylation. Mitochondria also play a role in many other essential cellular processes including metabolite synthesis and calcium storage. Therefore, maintaining a functional population of mitochondria is critical for cardiac function. Efficient degradation and replacement of dysfunctional mitoch...
متن کاملMyocardin-related transcription factor-A: mending a broken heart.
Ventricular remodeling following myocardial infarction (MI) is a complex process driven by the response of both the myocytic and the nonmyocytic components of the heart to dynamic mechanical and neurohumoral stimuli. Despite the advent of reperfusion therapy and the administration of drugs slowing the progression of heart failure, many patients experiencing a MI undergo a progressive decline in...
متن کاملSolid tumors after heart transplantation.
We have recently reported our experience in skin cancer after heart transplantation in 92 heart transplant recipients who survived more than 6 months after the operation, with an average follow-up period of 43.3 months [2]. In our series, 26 skin cancers were found in 14 patients, which represents a frequency of 15.2%. In addition, more than one skin cancer developed in 5 of the 14 patients dur...
متن کاملMenDing a Broken Heart: steM Cells anD CarDiaC repair
Cardiovascular disease (CVD), which includes hypertension, coronary heart disease (CHD), stroke, and congestive heart failure (CHF), has ranked as the number one cause of death in the United States every year since 1900 except 1918, when the nation struggled with an influenza epidemic. In 2002, CVD claimed roughly as many lives as cancer, chronic lower respiratory diseases, accidents, diabetes ...
متن کاملTreatment of end-stage renal failure after heart transplantation.
BACKGROUND Five to 10% of heart-transplant recipients develop end-stage renal failure (ESRF). Little is known about the outcome of these patients under renal replacement therapy. METHODS We conducted a retrospective study in 16 men (mean age 52.8+/-7.4 years at heart transplantation) who developed ESRF 5.3+/-2.1 years later. Results. Haemodialysis (HD) was the first-line treatment (mean Kt/V ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Transplantation
سال: 2018
ISSN: 2090-0007,2090-0015
DOI: 10.1155/2018/9739236